Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$680M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
UnitedHealth
UNH
|
+$393M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$381M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.24B |
| 2 |
Tesla
TSLA
|
+$450M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$444M |
| 4 |
TSMC
TSM
|
+$432M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.79% |
| 2 | Consumer Discretionary | 0.82% |
| 3 | Financials | 0.79% |
| 4 | Healthcare | 0.66% |
| 5 | Industrials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12201
Acurx Pharmaceuticals
ACXP
$6.06M
| $35.6K | ﹤0.01% |
+3,487
| New | +$28.1K |
|
|
IMDX
12202
Insight Molecular Diagnostics
IMDX
$145M
| $35.6K | ﹤0.01% |
11,795
-33,011
| -74% | -$99.8K |
|
|
BZAI
12203
PUT
Blaize Holdings
BZAI
$68.4M
| $35.5K | ﹤0.01% |
11,900
-1,900
| -14% | -$4.67K |
|
12204
Compugen
CGEN
$272M
| $35.3K | ﹤0.01% |
19,839
+4,345
| +28% | +$6.44K |
|
12205
CBAK Energy Technology Ltd
CBAT
$84.2M
| $35.3K | ﹤0.01% |
29,925
-63,324
| -68% | -$57K |
|
|
NOTV
12206
CALL
DELISTED
Inotiv
NOTV
| $35.3K | ﹤0.01% |
19,400
-251,500
| -93% | -$546K |
|
12207
Verrica Pharmaceuticals
VRCA
$84.9M
| $35.3K | ﹤0.01% |
6,659
+1,247
| +23% | +$6.71K |
|
|
CODX
12208
Co-Diagnostics
CODX
$7.69M
| $35K | ﹤0.01% |
4,169
-2,942
| -41% | -$27.5K |
|
12209
CALL
Gerdau
GGB
$8.55B
| $35K | ﹤0.01% |
12,000
-7,800
| -39% | -$21.4K |
|
12210
CALL
Marchex
MCHX
$80M
| $35K | ﹤0.01% |
+16,200
| New | +$26.6K |
|
|
PPSI
12211
CALL
Pioneer Power Solutions
PPSI
$31.6M
| $34.9K | ﹤0.01% |
12,700
-5,800
| -31% | -$15.6K |
|
12212
CALL
Torrid Holdings
CURV
$209M
| $34.8K | ﹤0.01% |
11,800
-7,200
| -38% | -$37.7K |
|
|
TPIC
12213
DELISTED
TPI Composites
TPIC
| $34.8K | ﹤0.01% |
40,485
-89,650
| -69% | -$91.1K |
|
12214
Beam Global
BEEM
$30.2M
| $34.8K | ﹤0.01% |
23,814
-300
| -1% | -$479 |
|
12215
Dolphin Entertainment
DLPN
$15.2M
| $34.6K | ﹤0.01% |
+30,127
| New | +$32.4K |
|
12216
PUT
Designer Brands
DBI
$297M
| $34.5K | ﹤0.01% |
14,500
-227,300
| -94% | -$686K |
|
12217
Aterian
ATER
$7.55M
| $34.5K | ﹤0.01% |
20,775
-79,985
| -79% | -$136K |
|
|
SVC
12218
PUT
Service Properties Trust
SVC
$1.03B
| $34.4K | ﹤0.01% |
2,880
-9,940
| -78% | -$107K |
|
12219
Asia Pacific Wire & Cable
APWC
$58.6M
| $34.4K | ﹤0.01% |
20,225
+5,102
| +34% | +$8.19K |
|
|
WPRT
12220
Westport Fuel Systems
WPRT
$35M
| $34.3K | ﹤0.01% |
11,022
-35,209
| -76% | -$102K |
|
12221
CALL
ReWalk Robotics
LFWD
$20.9M
| $34.2K | ﹤0.01% |
4,458
-734
| -14% | -$11.2K |
|
12222
IRIDEX
IRIX
$12.5M
| $34.1K | ﹤0.01% |
+38,636
| New | +$39.4K |
|
12223
PUT
CytomX Therapeutics
CTMX
$734M
| $33.8K | ﹤0.01% |
+14,900
| New | +$24K |
|
|
CISO
12224
CISO Global
CISO
$10.2M
| $33.5K | ﹤0.01% |
29,089
+14,059
| +94% | +$12.4K |
|
|
TMCWW
12225
TMC The Metals Company Warrants
TMCWW
$236K
| $33.4K | ﹤0.01% |
+22,714
| New | +$18.1K |
|
Similar funds
Jeff Yass's Q2 2025 Portfolio in Review
As of Q2 2025, Jeff Yass held 14,080 positions worth $720B, up 23% from $586B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass deployed $32.3B of net new capital in Q2 2025, opening 1,720 new positions and adding to 5,716 existing holdings. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $5.24B trimmed.
- Jeff Yass's largest Q2 2025 buy was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
- Jeff Yass added most to Apple in Q2 2025, an estimated $680M increase.
- Jeff Yass's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.24B.
- Jeff Yass fully exited Vanguard Intermediate-Term Bond ETF in Q2 2025, selling an estimated $61.8M.
- Jeff Yass's ten largest holdings make up 26% of its $720B portfolio in Q2 2025.
- Jeff Yass opened 1,720 new positions and closed 1,538 in Q2 2025.
- Jeff Yass's portfolio value rose 23% quarter-over-quarter to $720B.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.